Bioregenx (BRGX) EBITDA Margin (2022 - 2026)
Bioregenx's (BRGX) quarterly EBITDA Margin came in at 11.68% in Q1 2026, up 2571.0% year-on-year from 0.44% in Q1 2025, and up 95.24% quarter-over-quarter from 245.12% in Q4 2025.
Bioregenx (BRGX) EBITDA Margin (2022 - 2026) Analysis & Trends
Bioregenx's EBITDA Margin history runs 5 years deep, the most recent figure standing at 11.68% for Q1 2026.
- On a quarterly basis, EBITDA Margin rose 2571.0% year-over-year to 11.68% in Q1 2026; TTM through Mar 2026 was 62.42%, a 79876.0% increase from a year earlier, with the FY2025 full-year figure at 67.08%, up 80782.0% from the prior year.
- EBITDA Margin climbed to 11.68% in Q1 2026 per BRGX's latest filing, from 245.12% in the prior quarter.
- Across five years, EBITDA Margin topped out at 1.66% in Q3 2025 and bottomed at 3957.43% in Q4 2024.
- The 5-year median for EBITDA Margin is 61.69% (2023), against an average of 360.69%.
- Across the five-year window, EBITDA Margin slumped 393527 bps in 2024 and surged 371231 bps in 2025, its largest moves.
- Year by year, EBITDA Margin stood at 62.09% in 2022, then soared by 64 bps to 22.16% in 2023, then sank by 17756 bps to 3957.43% in 2024, then surged by 94 bps to 245.12% in 2025, then jumped by 95 bps to 11.68% in 2026.
- Per Business Quant, the three latest BRGX EBITDA Margin figures stand at 11.68% (Q1 2026), 245.12% (Q4 2025), and 1.66% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.50 Bn | 662.02 Mn | 30.93% |
| 2 | BrightSpring Health Services | 14.59 Bn | 13.69 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 8.32 Bn | 8.05 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 5.97 Bn | 5.65 Bn | 154.23 Mn | 17.59% |
| 5 | 10x Genomics | 5.78 Bn | 5.24 Bn | 106.18 Mn | -11.30% |
| 6 | MiniMed | 4.53 Bn | 4.23 Bn | 480.00 Mn | -11.11% |
| 7 | Waystar Holding | 4.49 Bn | 4.42 Bn | 216.84 Mn | 25.64% |
| 8 | Doximity | 3.99 Bn | 3.24 Bn | 125.97 Mn | 17.08% |
| 9 | Privia Health | 3.18 Bn | 2.76 Bn | - | 1.23% |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | -11.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.68% |
| Dec 31, 2025 | -245.12% |
| Sep 30, 2025 | -1.66% |
| Jun 30, 2025 | -24.01% |
| Mar 31, 2025 | -37.39% |
| Dec 31, 2024 | -3,957.43% |
| Sep 30, 2024 | -54.91% |
| Jun 30, 2024 | -141.66% |
| Mar 31, 2024 | -449.59% |
| Dec 31, 2023 | -22.16% |
| Sep 30, 2023 | -308.51% |
| Jun 30, 2023 | -61.69% |
| Mar 31, 2023 | -16.68% |
| Dec 31, 2022 | -62.09% |
| Sep 30, 2022 | -19.42% |
| Jun 30, 2022 | -233.29% |
| Mar 31, 2022 | -484.41% |